Faculty profile

Richard Kim

ResearcherPediatricsUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.

Signals and details

Research

Active Surveillance Adverse Drug Reactions Hepatitis C Therapy Pharmacogenomics

Latest funding

Active Surveillance for evaluation of harm of direct acting oral anticoagulants (DOACs) in real-world patients
CIHR · 2015 · Co-investigator
$250,000
DSEN active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare (DSEN SEARCH)
CIHR · 2014 · Co-investigator
$750,000
5-HT3 Antagonists (Antiemetics) & Cardiac Safety, Using an Active Surveillance Approach
CIHR · 2013 · Co-investigator
$424,700

All 7 grants and awards

Active Surveillance for evaluation of harm of direct acting oral anticoagulants (DOACs) in real-world patients

Co-investigatorCIHR2015Rapid Funding for DSEN Targeted Research

Principal investigators: Carleton, Bruce C; Ross, Colin J

Keywords: Active Surveillance

$250,000

DSEN active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare (DSEN SEARCH)

Co-investigatorCIHR2014Team Grant: DSEN Collab. Centre for Prospective Studies - Active Surveillance

Principal investigators: Carleton, Bruce C

Keywords: Active Surveillance; Adverse Drug Reactions; Drug Safety; Post-Market Safety Evaluation

$750,000

5-HT3 Antagonists (Antiemetics) & Cardiac Safety, Using an Active Surveillance Approach

Co-investigatorCIHR2013Rapid Funding for DSEN Targeted Research - Prospective Studies

Principal investigators: Carleton, Bruce C

Keywords: 5-Ht3 Antagonists; Active Surveillance; Adverse Drug Reactions; Antiemetics; Cardiac Safety; Qt Prolongation

$424,700

Optimizing Chronic Hepatitis C Treatment Using Pharmacogenomic Biomarkers

Principal investigatorCIHR2013Rapid Funding for DSEN Targeted Research - Prospective Studies

Principal investigators: Carleton, Bruce C; Kim, Richard B; Lee, Samuel S; Ross, Colin J

Keywords: Active Surveillance; Adverse Drug Reactions; Hepatitis C Therapy; Pharmacogenomics

$449,900

DSEN active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare (DSEN SEARCH)

Co-investigatorCIHR2011Team Grant: DSEN Collab. Centre for Prospective Studies - Active Surveillance

Principal investigators: Carleton, Bruce C; Hayden, Michael R

Keywords: Active Surveillance; Adverse Drug Reactions; Drug Safety; Post-Market Safety Evaluation

$921,950

Pharmacogenetics of Warfarin Safety and Effectiveness in Children.

Co-investigatorCIHR2011Catalyst Grant: Post Market Drug Safety and Effectiveness

Principal investigators: Ross, Colin J; Carleton, Bruce C

Keywords: Adverse Drug Reaction; Drug Effectiveness; Drug Safety; Pediatrics; Pharmacogenetics; Warfarin

$97,486

Drug Safety and Effectiveness Network (DSEN) Pharmacogenomics of Adverse Events National Team(PREVENT)

Principal investigatorCIHR2011Team Grant: DSEN Collab Ctre Prospective Studies -Pharmacogenomics of Adverse...

Principal investigators: Hayden, Michael R; Carleton, Bruce C; Kim, Richard B

Keywords: Adverse Drug Reaction; Drug Response; Drug Safety; Genetics; Genomics; Pharmacogenetics; Pharmacogenomics; Pharmacokinetics; Pharmacology

$1,606,959

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction